Tempus AI, Inc. (NASDAQ:TEM) Holdings Raised by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 1,591.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,217,699 shares of the company’s stock after buying an additional 1,145,698 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Tempus AI were worth $68,922,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. NEA Management Company LLC acquired a new stake in Tempus AI during the 2nd quarter worth about $160,048,000. Novo Holdings A S purchased a new position in Tempus AI during the second quarter valued at approximately $142,605,000. Revolution Growth Management Company Inc. acquired a new position in Tempus AI in the 2nd quarter valued at approximately $128,133,000. ARK Investment Management LLC lifted its position in Tempus AI by 355.0% in the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after buying an additional 1,855,459 shares in the last quarter. Finally, Alphabet Inc. acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $54,289,000.

Tempus AI Price Performance

Tempus AI stock opened at $56.63 on Friday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The stock’s fifty day moving average price is $51.21.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TEM. Needham & Company LLC reiterated a “buy” rating and set a $47.00 price objective on shares of Tempus AI in a report on Wednesday, August 7th. Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the company from $45.00 to $60.00 in a report on Wednesday, October 2nd. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and increased their price objective for the stock from $45.00 to $65.00 in a report on Monday. Piper Sandler reiterated a “neutral” rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a research note on Tuesday. Finally, Loop Capital increased their price target on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $54.22.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.